A Randomized, Controlled Trial of Combination Therapy for Chronic Hepatitis B: Comparing Pegylated Interferon-α2b and Lamivudine with Lamivudine Alone - Concepedia

Concepedia

Publication | Closed Access

A Randomized, Controlled Trial of Combination Therapy for Chronic Hepatitis B: Comparing Pegylated Interferon-α2b and Lamivudine with Lamivudine Alone

274

Citations

29

References

2005

Year

Henry Lik‐Yuen Chan, Nancy Leung, Alex Hui, Vincent Wai‐Sun Wong, Choong-Tsek Liew, Angel Mei–Ling Chim, Francis K.L. Chan, Lawrence Cheung–Tsui Hung, Yuk-Tong Lee, John S. Tam,

Annals of Internal Medicine

Abstract

In patients with HBeAg-positive chronic hepatitis B, staggered combination treatment with pegylated interferon-alpha2b and lamivudine may lead to a higher rate of virologic response than lamivudine monotherapy.

References

	Year	Citations

Page 1